MitoRx Therapeutics
Biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases
MitoRx Therapeutics has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Oxford, UK; active in Healthtech. Data as of 28 Oct 2026.
Oxford, UKwww.mitorxtherapeutics.com ↗
Total raised
€0
€0
Funding rounds
1
Investors
7
distinct backers
Active since
2022-04
latest 2022-04
Funding by year
EUR raised per yearMitoRx Therapeutics — funding by year — interactive chart.
Data table
| MitoRx Therapeutics — funding by year | |
|---|---|
| 2022 | €0 |
Signals
Medium confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-25 | Seed | — | Angel Investors,Longevitytech.fund,Oxford Technology Management,Science Angel Syndicate Network,The Fink Family Office,UK Innovation & Science Seed Fund+1 more | View deal → |
Investors
7Related news
- MitoRx Therapeutics Raises Seed Financingfinsmes.com · 2022-04
Similar companies
same sector or countryGlobal coverage: FundingData